The FSHD Society Celebrates Fulcrum’s Milestone in the Fight Against FSHD
Posted on September 8th, 20239/8/23
Fulcrum Therapeutics has announced successful completion of patient enrollment in REACH Phase 3 trial The FSHD Society is thrilled to announce a significant milestone in the battle against FSHD. Fulcrum […]
Filed under: FSHD Research, FSHD Society News